Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating hyperuricemia under examination

A technology for hyperuricemia and a composition, applied in the field of medicine, can solve the problems of many side effects and unsuitable long-term use and the like

Inactive Publication Date: 2014-11-19
王洪燕
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Western medicine generally uses colchicine and non-steroidal anti-inflammatory drugs for combined treatment, but due to many side effects, it is not suitable for long-term use

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for treating hyperuricemia under examination

Examples

Experimental program
Comparison scheme
Effect test

experiment example

[0016] The most common clinical symptom of hyperuricemia is primary acute gout, so this experimental example uses the treatment of primary acute gout to illustrate the therapeutic effect of the composition of the present invention.

[0017] Diagnostic criteria

[0018] Referring to the criteria established by the American Rheumatology Association in 1997: ① more than one attack of acute arthritis and climax within 24 hours; ② acute inflammation limited to individual joints; ③ dark red color of the entire joint; ④ swelling and pain of the first toe joint; ⑤ Acute inflammation of the unilateral toe joint; ⑥ Gouty nodules with doubtful confirmation; ⑦ Hyperuricemia; ⑧ Asymmetric joint swelling; ⑨ Attacks can end spontaneously. Having at least 4 of them and excluding secondary gout can be diagnosed as primary acute gout.

[0019] normal information

[0020] A total of 30 observed cases met the diagnostic criteria, including 15 males and 15 females, aged 21-62 years, with an aver...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a pharmaceutical composition for treating hyperuricemia under examination. The composition is composed of the following components in parts by weight: 1 to 10 parts of ligusticum wallichii, 1 to 15 parts of snake gourd peel, 5 to 20 parts of balloonflower root, 1 to 10 parts of herb of tonkin pepper, 5 to 15 parts of dalbergia wood, 10 to 30 parts of primula forbesii, 1 to 10 parts of madder, 10 to 20 parts of hydrangea paniculata, 1 to 5 parts of tsaoko fruit, 1 to 10 parts of rhizoma nardostachyos, 5 to 20 parts of clematis root, 10 to 30 parts of white flower azalea, 1 to 10 parts of licorice, 1 to 10 parts of fenugreek, 10 to 30 parts of arundina graminifolia, 1 to 30 parts of baeckea frutescens, 1 to 10 parts of kadsura longepedunculata, 1 to 10 parts of wolfberry, 5 to 15 parts of swertia pseudochinensis, and 1 to 5 parts of lamiophlomis rotata. The pharmaceutical composition has the functions of resolving dampness, purging turbidity, freeing the collaterals, and relieving pains, can inhibit the formation of uric acid, and thus effectively treats hyperuricemia.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a pharmaceutical composition used in testing for treating hyperuricemia. Background technique [0002] Hyperuricemia, also known as gout, is a group of diseases caused by purine metabolism disorders or uric acid excretion disorders. With the improvement of people's living standards and changes in diet structure, the incidence of gout in my country is on the rise. Western medicine generally uses colchicine and non-steroidal anti-inflammatory drugs for combined treatment, but due to many side effects, it is not suitable for long-term use. Contents of the invention [0003] The object of the present invention is to provide a pharmaceutical composition for treating hyperuricemia in the test. [0004] In order to achieve the purpose of the present invention, the present invention provides a pharmaceutical composition for the treatment of hyperuricemia in a test, which comprises the followi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9064A61P19/06
Inventor 王洪燕
Owner 王洪燕
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com